reverse merger – Talk Bio

Barinthus Biotherapeutics Announces Reverse Merger with Clywedog Therapeutics to Form New Metabolic Disease-Focused Company

4 weeks ago talkbio0Tagged Autoimmune Diseases, Barinthus, biotherapeutics, Board Composition, Clywedog Therapeutics, Delaware merger, lock-up, Menstruation, Metabolic Diseases, reverse merger, Scheme of Arrangement, Shareholder Ownership Structure, Topco, UK

Barinthus Biotherapeutics; Reverse Merger; Clywedog Therapeutics; Metabolic Diseases; Autoimmune Diseases; Topco; Shareholder Ownership Structure; UK Scheme of Arrangement; Delaware Merger; Self-Tender Offer; Lock-Up Period; Board Composition

Jade Biosciences and Aerovate Therapeutics Announce Strategic Merger to Advance Autoimmune Disease Therapies

12 months ago talkbio0Tagged Autoimmune Diseases, Biosciences, Biotechnology, IGA Glomerulonephritis, paragon, reverse merger

Reverse merger, Jade Biosciences, Aerovate Therapeutics, Paragon Therapeutics, Autoimmune diseases, JADE-001, IgA nephropathy (IgAN), Biotechnology

Insights from Jade CEO: Reverse Merger and IgAN Drug Development

12 months ago talkbio0Tagged biotech, CEO, Drug Development, IGA Glomerulonephritis, mergers, reverse merger

Jade CEO, Reverse Merger, IgAN Drugs, Pharmaceutical Development, Biotech Mergers